John Northcott

Overview

John Northcott received an average of $5M in total compensation, including $469K in salary, at Nektar Therapeutics from 2019 to 2021.

Source: SEC filings on April 29, 2022 and April 30, 2021.

Related executives

We found 20 more executives who work or worked at Nektar Therapeutics.

Howard Robin

Nektar Therapeutics

Chief Executive Officer

Gil Labrucherie

Nektar Therapeutics

Chief Financial Officer

Jonathan Zalevsky

Nektar Therapeutics

Senior Vice President and Chief Research and Development Officer

Mark Wilson

Nektar Therapeutics

General Counsel

Jillian Thomsen

Nektar Therapeutics

Chief Accounting Officer

Stephen Doberstein

Nektar Therapeutics

Chief Research and Development Officer

Maninder Hora

Nektar Therapeutics

Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer

John Nicholson

Nektar Therapeutics

Chief Operating Officer

News

You may also like